Carrick Therapeutics
PrivateLast Round
Series D
Dec 1, 2022
Total Funding Raised
$190M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Carrick Therapeutics is a biotechnology company that develops innovative cancer therapeutics targeting molecular pathways to improve treatment outcomes for patients with aggressive and resistant forms of cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Carrick Therapeutics Comparables
Compare Carrick Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Syros Pharmaceuticals Inc | 82% | |
| Avenzo Therapeutics | 79% | |
| Incyclix Bio | 79% | |
Carrick Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Dec 1, 2022 | ||||
| Series B | Nov 14, 2019 | ||||
| Series A | Oct 3, 2016 |
Carrick Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| EQT Life Sciences | Series B |
| SV Health Investors | Series A |
| GV | Series A, Series B, Series D |
| Lightstone Ventures | Series B, Series D, Series A |
| ARCH Venture Partners | Series D, Series A |
| Woodford Investment Management | Series B, Series A |
| ARCH Venture Partners | Series B, Series D, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 20, 2026
Monthly visitors grew 249% MoM, reaching 2.5K.
- Dec 1, 2022
$35M round led by Pfizer.
Carrick Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Carrick Therapeutics's valuation, stock price, and market status.